Medicenna Therapeutics

$4.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.45%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell MDNA and other stocks, options, and ETFs commission-free!

About MDNA

Medicenna Therapeutics Corp. Common Shares, also called Medicenna Therapeutics, is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada. The listed name for MDNA is Medicenna Therapeutics Corp. Common Shares.

CEO
Fahar Merchant
Employees
7
Headquarters
Toronto, Ontario
Founded
2015
Market Cap
213.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
285.76K
High Today
$4.62
Low Today
$4.34
Open Price
$4.56
Volume
469.82K
52 Week High
$6.84
52 Week Low
$1.46

Collections

You May Also Like

WEICY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure